Michael Kennedy, Ph.D.
About Michael Kennedy, Ph.D.
Michael Kennedy, Ph.D., serves as the Director of Drug Product at Deciphera Pharmaceuticals, bringing extensive experience from his previous roles at Amgen, Inc. He holds a Ph.D. in Chemical Engineering and has a strong background in GMPs, regulatory compliance, and technology assessment.
Current Role at Deciphera Pharmaceuticals
Michael Kennedy, Ph.D. serves as the Director of Drug Product at Deciphera Pharmaceuticals since 2019. In this role, he is responsible for overseeing the development and manufacturing of drug products, ensuring compliance with industry standards and regulations. His position involves strategic planning and execution of drug formulation processes, contributing to the advancement of therapeutic candidates within the organization.
Previous Experience at Amgen, Inc.
Prior to his current role, Michael Kennedy worked at Amgen, Inc. for over 20 years in various capacities. He held positions such as Principal Scientist, Senior Scientist, and Research Scientist, focusing on small molecule pharmaceutics and sustained release technologies. His tenure at Amgen included significant contributions to drug product development and regulatory compliance, where he authored CMC sections for regulatory filings.
Education and Expertise
Michael Kennedy holds a Doctor of Philosophy (Ph.D.) in Chemical Engineering from UC Santa Barbara, where he studied from 1993 to 1998. He also earned a Master of Arts (MA) in Business Economics from the same institution. Earlier, he completed a Bachelor of Science (BS) in Chemical Engineering at Cornell University from 1989 to 1993. His educational background equips him with a strong foundation in both technical and business aspects of drug development.
Technical Skills and Knowledge
Michael Kennedy possesses extensive knowledge of Good Manufacturing Practices (GMPs) for clinical manufacturing and the commercialization process. He is skilled in experimental planning, data analysis, troubleshooting, and method development, particularly in the context of drug formulation. His experience includes assessing technology landscapes to develop intellectual property strategies and leading efforts in process unit operations design.
Achievements in Drug Product Development
Throughout his career, Michael Kennedy has led initiatives to develop and transfer enabling technology platforms at Amgen, resulting in numerous innovations for the Drug Product organization. His work has involved a blend of technical expertise and business development, showcasing his ability to evaluate new opportunities and drive advancements in drug formulation and manufacturing processes.